Trials / Unknown
UnknownNCT00599482
Far Infrared Radiation for Sickle Cell Pain Management
Phase 1 Study to Examine the Use of Far Infrared Radiation for Pain Management During Sickle Cell Crisis
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- GAAD Medical Research Institute Inc. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.
Detailed description
Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue. It is hereby postulated that far infrared radiation of the body will promote blood and oxygen supply to the affected tissues. In addition, the analgesic properties of far infrared will alleviate pain due to the crisis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Far Infrared Radiation (5μm to 20μm wavelength) | Far infrared radiation for 30 to 40 minutes during each session. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-09-01
- Completion
- 2009-01-01
- First posted
- 2008-01-23
- Last updated
- 2009-01-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00599482. Inclusion in this directory is not an endorsement.